MEDEZE Targets Record-High Revenue of Over 1 Billion THB in 2025 Invests 552 MB Acquiring Land for New Cell Bank to Support Expansion
MEDEZE Group sets 2025 goal to surpass 1 billion THB in revenue, achieving yet another record high. The company moved forward with expansion into hair follicle cell banking and international markets, acquiring land as part of long-term plan for new cell bank in response to rising demand. This move aligns with government initiatives promoting stem cell advancements into ATMPs.
Dr. Veerapol Khemarangsan, Chief Executive Officer of MEDEZE Group Public Company Limited (MEDEZE), revealed that the company targets a revenue growth of 25-30% in 2025, exceeding 1 billion THB following the company's record-breaking revenue of 897.22 million THB in 2024.
The company’s primary growth drivers include the continuous expansion of its domestic stem cell analysis, isolation, cultivation, and storage services. The Group has strengthened sales team and expanding network of authorized dealers and agents, enabling broader access to customers seeking stem cell storage solutions as well as a partnership network of medical professionals and healthcare institutions. Furthermore, it also recently launched MEDEZE Hair Renaissance, Asia’s first hair follicle cell cryopreservation bank which offers cell analysis, isolation, cultivation, and storage. The new business aims to serve 500 cases in 2025 and expand its clientele to 5,000 cases by 2030.
Simultaneously, the company is advancing its biotechnology business in the Philippines by establishing the Cell Banking Biotechnology, a facility which includes high-performance laboratories dedicated to stem cell analysis, isolation, cultivation, and storage, catering to the potential growth for stem cell banking in the Philippines. Additionally, the company expects to see a steady increase in revenue from international business consulting services and licensing fees from overseas service providers operating under the MEDEZE brand.
For long-term expansion, MEDEZE has acquired a 30-rai plot of land, valued at 552 million THB, to enhance the company’s operational capabilities and accommodate long-term growth following the continued growth of stem cell market trend in both domestic and international customer bases. The market is bolstered by Thai government’s strong support for the stem cell industry, categorizing it as a high-tech innovation sector under the ATMPs, Advanced Therapy Medicinal Products, classification. The government has also outlined clear plans to promote stem cell businesses as a key driver of the national economy. Additionally, MEDEZE also emphasizes the development of AI Smart System “MEDEZE Plus Auto Matching Software” designed to analyze social media data and investor behavior, investing 12 million THB in the development. This AI-powered platform will enhance the company’s market targeting accuracy and improve engagement with potential investors.
IR Press Releases